Feng Qian, MD, PhD, MBA

Original Contribution

Can Adding Laboratory Values Improve Risk-Adjustment Mortality Models Using Clinical Percutaneous Cardiac Intervention Registry Data?

06/29/2015

Feng Qian , MD, PhD, MBA;

Edward L. Hannan , PhD, MS;

Michael Pine , MD, MBA;

Kay Whitman ;

Barbara A. Dennison , MD;

Donald Fry ;

Registry data for percutaneous coronary intervention (PCI) are being used to risk-adjust provider mortality rates; these registries contain very few numerical laboratory data for risk adjustment. The pros and cons of adding key laboratory...

Registry data for percutaneous...

06/29/2015

Journal of Invasive Cardiology

Original Contribution

Utilization Trends and Short-Term Outcomes for Transcatheter and Surgical Aortic Valve Replacement Surgery in New York

12/09/2022

Feng Qian , MD, PhD, MBA;

Zaza Samadashvili , MD, MPH, MA;

Edward L. Hannan , PhD, MS;

We described the utilization trends, compared baseline characteristics, and evaluated short-term outcomes of TAVR vs SAVR during 2011-2018 in New York. We applied Cox proportional hazards models to analyze changes in 30-day postoperative...

We described the utilization...

12/09/2022

Journal of Invasive Cardiology